Patents by Inventor Xinping Wu

Xinping Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11975125
    Abstract: Described are medical devices including expandable tubular bodies configured to be implanted into a lumen, wherein the outer surface of the expandable tubular bodies are coupled to a polymer(s).
    Type: Grant
    Filed: February 24, 2023
    Date of Patent: May 7, 2024
    Assignee: MicroVention, Inc.
    Inventors: Aaron Baldwin, Xinping Wu, Bryan Fiamengo, Garrett Ulrich, John Belletto
  • Publication number: 20240091403
    Abstract: Embolic particles are described. The particles are reaction products of a prepolymer solution including at least one polyether macromer and an appropriate monomer.
    Type: Application
    Filed: November 15, 2023
    Publication date: March 21, 2024
    Inventors: Gregory M. Cruise, Steve Plotkin, Xinping Wu
  • Patent number: 11857694
    Abstract: Embolic particles are described. The particles are reaction products of a prepolymer solution including at least one polyether macromer and an appropriate monomer.
    Type: Grant
    Filed: February 23, 2022
    Date of Patent: January 2, 2024
    Assignee: MicroVention, Inc.
    Inventors: Gregory M. Cruise, Steve Plotkin, Xinping Wu
  • Publication number: 20230381370
    Abstract: Biodegradable, cross-linked polymer particle embolics and methods of making the same are described. The particle embolics can be used as embolization agents.
    Type: Application
    Filed: August 4, 2023
    Publication date: November 30, 2023
    Inventors: Gloria Hincapie, Xinping Wu, Yue Wu, Gregory M. Cruise
  • Publication number: 20230330309
    Abstract: Described are medical devices including expandable tubular bodies configured to be implanted into a lumen, wherein the outer surface of the expandable tubular bodies are coupled to a polymer(s).
    Type: Application
    Filed: February 24, 2023
    Publication date: October 19, 2023
    Inventors: Aaron Baldwin, Xinping Wu, Bryan Fiamengo, Garrett Ulrich, John Belletto
  • Publication number: 20230303743
    Abstract: Described herein are polymeric coatings, methods of preparing the polymeric coatings, methods of using the polymeric coatings, and substrates including one or more surfaces coated with the polymeric coatings.
    Type: Application
    Filed: August 31, 2021
    Publication date: September 28, 2023
    Inventors: Gregory M. Cruise, Xinping Wu
  • Patent number: 11759545
    Abstract: Biodegradable, cross-linked polymer particle embolics and methods of making the same are described. The particle embolics can be used as embolization agents.
    Type: Grant
    Filed: August 3, 2021
    Date of Patent: September 19, 2023
    Assignee: Terumo Corporation
    Inventors: Gloria Hincapie, Xinping Wu, Yue Wu, Gregory M. Cruise
  • Publication number: 20230190991
    Abstract: Described are polymers and methods of forming and using same.
    Type: Application
    Filed: February 21, 2023
    Publication date: June 22, 2023
    Inventors: Gregory M. Cruise, Xinping Wu, Gloria Hincapie, Yue Wu
  • Patent number: 11617814
    Abstract: Described herein are polymeric particles configured for intravascular delivery of pharmaceutical agents, e.g., to a diseased site, and methods of forming and using same. Preparation of these polymer particles is also described.
    Type: Grant
    Filed: June 26, 2020
    Date of Patent: April 4, 2023
    Assignee: Terumo Corporation
    Inventors: Gregory M. Cruise, Xinping Wu, Gloria Hincapie, Yue Wu
  • Publication number: 20230099559
    Abstract: Described are medical devices including expandable tubular bodies configured to be implanted into a lumen, wherein the outer surface of the expandable tubular bodies are coupled to a polymer(s).
    Type: Application
    Filed: September 9, 2022
    Publication date: March 30, 2023
    Inventors: Xinping Wu, Jodi Hong, Gregory M. Cruise
  • Patent number: 11590267
    Abstract: Described are medical devices including expandable tubular bodies configured to be implanted into a lumen, wherein the outer surface of the expandable tubular bodies are coupled to a polymer(s).
    Type: Grant
    Filed: October 1, 2019
    Date of Patent: February 28, 2023
    Assignee: MicroVention, Inc.
    Inventors: Aaron Baldwin, Xinping Wu, Bryan Fiamengo, Garrett Ulrich, John Belletto
  • Patent number: 11439494
    Abstract: Described are medical devices including expandable tubular bodies configured to be implanted into a lumen, wherein the outer surface of the expandable tubular bodies are coupled to a polymer(s).
    Type: Grant
    Filed: May 11, 2018
    Date of Patent: September 13, 2022
    Assignee: MicroVention, Inc.
    Inventors: Xinping Wu, Jodi Hong, Gregory M. Cruise
  • Publication number: 20220176012
    Abstract: Embolic particles are described. The particles are reaction products of a prepolymer solution including at least one polyether macromer and an appropriate monomer.
    Type: Application
    Filed: February 23, 2022
    Publication date: June 9, 2022
    Inventors: Gregory M. Cruise, Steve Plotkin, Xinping Wu
  • Publication number: 20220162470
    Abstract: Described herein are surface-treated polymeric substrates. Also described herein are polymeric coatings, which may be used as surface treatments.
    Type: Application
    Filed: November 24, 2021
    Publication date: May 26, 2022
    Inventors: Xinping Wu, Petr Vasek, Steve Plotkin, Gregory M. Cruise
  • Patent number: 11285240
    Abstract: Embolic particles are described. The particles are reaction products of a prepolymer solution including at least one polyether macromer and an appropriate monomer.
    Type: Grant
    Filed: September 2, 2020
    Date of Patent: March 29, 2022
    Assignee: MicroVention, Inc.
    Inventors: Gregory M. Cruise, Steve Plotkin, Xinping Wu
  • Publication number: 20210361823
    Abstract: Biodegradable, cross-linked polymer particle embolics and methods of making the same are described. The particle embolics can be used as embolization agents.
    Type: Application
    Filed: August 3, 2021
    Publication date: November 25, 2021
    Inventors: Gloria Hincapie, Xinping Wu, Yue Wu, Gregory M. Cruise
  • Patent number: 11110198
    Abstract: Biodegradable, cross-linked polymer particle embolics and methods of making the same are described. The particle embolics can be used as embolization agents.
    Type: Grant
    Filed: March 17, 2020
    Date of Patent: September 7, 2021
    Assignee: Terumo Corporation
    Inventors: Gloría Hincapie, Xinping Wu, Yue Wu, Gregory M. Cruise
  • Patent number: 10988466
    Abstract: This invention relates to certain novel pyrazine derivatives (Formula I) as SHP2 inhibitors which is shown as formula I, their synthesis and their use for treating a SHP2 mediated disorder. More particularly, this invention is directed to fused heterocyclic group derivatives useful as inhibitors of SHP2, methods for producing such compounds and methods for treating a SHP2-mediated disorder.
    Type: Grant
    Filed: March 23, 2018
    Date of Patent: April 27, 2021
    Assignee: Jacobio Pharmaceuticals Co., Ltd.
    Inventors: Cunbo Ma, Panliang Gao, Shaojing Hu, Zilong Xu, Huifeng Han, Xinping Wu, Di Kang
  • Publication number: 20200397942
    Abstract: Embolic particles are described. The particles are reaction products of a prepolymer solution including at least one polyether macromer and an appropriate monomer.
    Type: Application
    Filed: September 2, 2020
    Publication date: December 24, 2020
    Inventors: Gregory M. Cruise, Steve Plotkin, Xinping Wu
  • Publication number: 20200392128
    Abstract: This invention relates to certain novel pyrazine derivatives (Formula I) as SHP2 inhibitors which is shown as formula I, their synthesis and their use for treating a SHP2 mediated disorder. More particularly, this invention is directed to fused heterocyclic group derivatives useful as inhibitors of SHP2, methods for producing such compounds and methods for treating a SHP2-mediated disorder.
    Type: Application
    Filed: March 23, 2018
    Publication date: December 17, 2020
    Inventors: Cunbo Ma, Panliang Gao, Shaojing Hu, Zilong Xu, Huifeng Han, Xinping Wu, Di Kang